Research output per year
Research output per year
- 1 - 50 out of 153 results
Search results
-
2025
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Phillips, E. H., Counsell, N., Illidge, T. M., André, M., Aurer, I., Fiaccadori, V., Fortpied, C., Neven, A., Federico, M., Barrington, S. F., Raemaekers, J. M. & Radford, J., 7 Jan 2025, (E-pub ahead of print) In: Blood Advances.Research output: Contribution to journal › Article › peer-review
Open Access -
2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK
Kuhnl, A., Roddie, C., Kirkwood, A. A., Chaganti, S., Norman, J., Lugthart, S., Osborne, W., Gibb, A., Gonzalez Arias, C., Latif, A., Uttenthal, B., Seymour, F., Jones, C., Springell, D., Brady, J. L., Illidge, T., Stevens, A., Alexander, E., Hawley, L. & O'Rourke, N. & 8 others, , Aug 2024, In: British Journal of Haematology. 205, 2, p. 483-494 12 p.Research output: Contribution to journal › Article › peer-review
-
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline
Fox, C. P., Chaganti, S., Mcilroy, G., Barrington, S. F., Burton, C., Cwynarski, K., Eyre, T. A., Illidge, T., Kalakonda, N., Kuhnl, A., Mckay, P. & Davies, A. J., 10 Apr 2024, In: British Journal of Haematology. 204, 4, p. 1178-1192 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer
Smith, V., Lee, D., Reardon, M., Shabbir, R., Sahoo, S., Hoskin, P., Choudhury, A., Illidge, T. & West, C. M. L., 18 May 2023, In: International Journal of Molecular Sciences. 24, 10, 8956.Research output: Contribution to journal › Article › peer-review
Open Access -
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials
Fiaccadori, V., Neven, A., Fortpied, C., Aurer, I., Andre, M., Federico, M., Counsell, N., Phillips, E. H., Clifton-Hadley, L., Barrington, S. F., Illidge, T., Radford, J. & Raemaekers, J. M. M., 1 Mar 2023, In: British Journal of Haematology. 200, 6, p. 731-739 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
Mukherjee, D., Romano, E., Walshaw, R., Zeef, L., Banyard, A., Kitcatt, S., Cheadle, E., Tuomela, K., Pendharkar, S., al-deka, A., salerno, B., Raby, S., Mills, I. G., Honeychurch, J. & Illidge, T., 2023, In: OncoImmunology.Research output: Contribution to journal › Article › peer-review
-
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
Fagnano, E., Pendharkar, S., Colton, M., Jones, P. N., Sallan, M. C., Klymenko, T., Braun, A., Klein, C., Honeychurch, J., Cheadle, E. J. & Illidge, T. M., 31 Oct 2023, In: Frontiers in cell and developmental biology. 11, 15 p., 1270398.Research output: Contribution to journal › Article › peer-review
-
2022
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
Assaf, C., Waser, N., Bagot, M., He, M., Li, T., Dalal, M., Gavini, F., Trinchese, F., Zomas, A., Little, M., Pimpinelli, N., Ortiz-Romero, P. L. & Illidge, T. M., 1 Jan 2022, In: Cancers. 14, 1, 17 p., 145.Research output: Contribution to journal › Article › peer-review
Open Access -
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline
Fox, C. P., Ahearne, M. J., Pettengell, R., Dearden, C. E., El-Sharkawi, D., Kassam, S., Cook, L., Cwynarski, K., Illidge, T. & Collins, G., Feb 2022, In: British Journal of Haematology|B J H. 196, 3, p. 507-522Research output: Contribution to journal › Article › peer-review
Open AccessFile334 Downloads (Pure) -
IRF7 impacts on prostate cancer cell survival in response to radiation
Pickard, A., Amoroso, F., McCulloch, K., Erickson, A., Sachdeva, A., Steele, R., Mukherjee, D., Dellett, M., McComb, J., McCaffery, L., Hart, C. A., Brown, M. D., McDade, S., Waugh, D., Clarke, N., Butterworth, K., Illidge, T., Mirtti, T., Overton, I. M. & Mills, I. G., 23 Sept 2022, In: bioRxiv.Research output: Contribution to journal › Article
-
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer
Smith, V., Mukherjee, D., Tsakiroglou, A. M., Baker, A., Mistry, H., Choudhury, A., Hoskin, P., Illidge, T. & West, C. M. L., 21 Dec 2022, In: Cancers. 15, 1, 41.Research output: Contribution to journal › Article › peer-review
Open Access -
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
Price, J. M., Mistry, H. B., Betts, G., Cheadle, E. J., Dixon, L., Garcez, K., Illidge, T., Iyizoba-Ebozue, Z., Lee, L. W., McPartlin, A., Prestwich, R. J. D., Papageorgiou, S., Pritchard, D. J., Sykes, A., West, C. M. & Thomson, D. J., 6 Apr 2022, (E-pub ahead of print) In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. p. JCO2101991Research output: Contribution to journal › Article › peer-review
-
Pre-treatment lymphocyte count predicts benefit from concurrent chemotherapy with radiotherapy in oropharynx cancer
Price, J., Mistry, H., Betts, G., Cheadle, E., Dixon, L., Garcez, K., Illidge, T., Iyizoba-Ebozue, Z., Lee, L., Mcpartlin, A., Papageorgiou, S., Prestwich, R., Pritchard, D., Sykes, A. J., West, C. & Thomson, D., 9 Mar 2022, (Accepted/In press) In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
-
2021
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial
Hoskin, P., Popova, B., Schofield, O., Brammer, C., Robinson, M., Brunt, A. M., Madhavan, K., Illidge, T., Gallop-Evans, E., Syndikus, I., Clifton-Hadley, L. & Kirkwood, A. A., 1 Mar 2021, In: The Lancet. Oncology. 22, 3, p. 332-340 9 p.Research output: Contribution to journal › Article › peer-review
-
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control
Nakamura, K., Karmokar, A., Farrington, P. M., James, N. H., Ramos-Montoya, A., Bickerton, S. J., Hughes, G. D., Illidge, T. M., Cadogan, E. B., Davies, B. R., Dovedi, S. J. & Valge-Archer, V., 1 Aug 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 27, 15, p. 4353-4366 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma
Cutter, D. J., Ramroth, J., Diez, P., Buckle, A., Ntentas, G., Popova, B., Clifton-Hadley, L., Hoskin, P. J., Darby, S. C., Radford, J. & Illidge, T., 13 Aug 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. JCO.21.00408.Research output: Contribution to journal › Article › peer-review
Open AccessFile147 Downloads (Pure) -
Progress and pitfalls with the use of image-guided personalised approaches in lymphoma
Illidge, T. & Phillips, B., 14 Sept 2021, In: British Journal of Radiology . 94, p. 20210609Research output: Contribution to journal › Article › peer-review
-
Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
Romano, E., Honeychurch, J. & Illidge, T. M., 26 Jan 2021, In: Cancers. 13, 3, p. 1-23 23 p., 457.Research output: Contribution to journal › Article › peer-review
Open Access -
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort
Martinez-Calle, N., Kirkwood, A. A., Lamb, M., Smith, A., Khwaja, J., Manos, K., Shrubsole, C., Gray, N., Lewis, K., Tivey, A., Bishton, M. J., Hawkes, E., Ahearne, M. J., Osborne, W., Collins, G. P., Illidge, T., Linton, K. M., Cwynarski, K., Burton, C. & Fox, C. P., Jul 2021, In: Advances in Therapy. 38, 7, p. 3789-3802 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile73 Downloads (Pure) -
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
Horwitz, S., O'Connor, O. A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P. & Shustov, A. & 10 others, , 16 Dec 2021, In: Annals of oncology : official journal of the European Society for Medical Oncology. 33, 3, p. 288-298 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The effect of hypoxia on PD-L1 expression in bladder cancer
Smith, V., Mukherjee, D., Lunj, S., Choudhury, A., Hoskin, P., West, C. & Illidge, T., 25 Nov 2021, In: BMC Cancer. 21, 1, p. 1271 1271.Research output: Contribution to journal › Article › peer-review
Open Access -
2020
ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic
Yahalom, J., Dabaja, B. S., Ricardi, U., Ng, A., Mikhaeel, N. G., Vogelius, I. R., Illidge, T., Qi, S., Wirth, A. & Specht, L., 21 May 2020, In: Blood. 135, 21, p. 1829-1832Research output: Contribution to journal › Article › peer-review
-
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer
Haughey, C. M., Mukherjee, D., Steele, R. E., Popple, A., Dura-Perez, L., Pickard, A., Patel, M., Jain, S., Mullan, P. B., Williams, R., Oliveira, P., Buckley, N. E., Honeychurch, J., S McDade, S., Illidge, T., Mills, I. G. & Eddie, S. L., 29 Sept 2020, In: Cancers. 12, 10Research output: Contribution to journal › Article › peer-review
Open AccessFile136 Downloads (Pure) -
Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.
Wirth, A., Mikhaeel, N. G., Aleman, B. M. P., Pinnix, C. C., Constine, L. S., Ricardi, U., Illidge, T., Eich, H. T., Hoppe, B. S., Dabaja, B., Ng, A. K., Kirova, Y. M., Berthelsen, A. K., Dieckmann, K., Yahalom, J. & Specht, L., 1 Aug 2020, In: Int J Radiat Oncol Biol Phys. 107, 5, p. 909-933Research output: Contribution to journal › Article › peer-review
Open Access -
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
Illidge, T., Phillips, E. H., Counsell, N., Pettengell, R., Johnson, P., Culligan, D., Popova, B., Clifton-Hadley, L., McMillan, A., Hoskin, P., Barrington, S. F. & Radford, J., 14 Jan 2020, In: Blood Advances. 4, 1, p. 203-206 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile77 Downloads (Pure) -
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Kolstad, A., Illidge, T., Bolstad, N., Spetalen, S., Madsbu, U., Stokke, C., Blakkisrud, J., Løndalen, A., O'Rourke, N., Beasley, M., Jurczak, W., Fagerli, U.-M., Kaščák, M., Bayne, M., Obr, A., Dahle, J., Rojkjaer, L., Pascal, V. & Holte, H., 8 Sept 2020, In: Blood Advances. 4, 17, p. 4091-4101 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase I/IIa study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin's lymphoma
Illidge, T., Jun 2020, (Accepted/In press) In: Blood Advances.Research output: Contribution to journal › Article › peer-review
-
Reprogramming the tumour microenvironment by radiotherapy: Implications for radiotherapy and immunotherapy combinations.
Colton, M., Cheadle, E., Honeychurch, J. & Illidge, T., 21 Sept 2020, (Accepted/In press) In: Radiation Oncology .Research output: Contribution to journal › Article › peer-review
-
The investigation and management of follicular lymphoma
McNamara, C., Montoto, S., Eyre, T. A., Ardeshna, K., Burton, C., Illidge, T., Linton, K., Rule, S., Townsend, W., Wong, W. L. & Mckay, P., 24 Jun 2020, In: Br J Haematol 2005;129: 746-754..Research output: Contribution to journal › Article › peer-review
Open Access -
Toll-like receptor agonists and RT combinations – an untapped opportunity to induce anti-cancer immunity and improve tumor control
Walshaw, R. C., Honeychurch, J., Choudhury, A. & Illidge, T. M., 2020, In: International Journal of Radiation: Oncology - Biology - Physics.Research output: Contribution to journal › Article › peer-review
Open AccessFile66 Downloads (Pure) -
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response
Cheng, S., Cheadle, E. J. & Illidge, T. M., 30 Sept 2020, (E-pub ahead of print) In: Cancers. 12, 10, p. 2835Research output: Contribution to journal › Article › peer-review
Open Access -
2019
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
ECHELON-2 Study Group, 19 Jan 2019, In: Lancet (London, England). 393, 10168, p. 229-240 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile167 Downloads (Pure) -
Evaluation of apoptosis imaging biomarkers in a genetic model of cell death
Vassileva, V., Stribbling, S. M., Barnes, C., Carroll, L., Braga, M., Abrahams, J., Heinzmann, K., Haegeman, C., MacFarlane, M., Simpson, K. L., Dive, C., Honeychurch, J., Illidge, T. M. & Aboagye, E. O., 2019, In: EJNMMI Research. 9, 18.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom
Bröckelmann, P. J., Mcmullen, S., Wilson, J. B., Mueller, K., Goring, S., Stamatoullas, A., Zagadailov, E., Gautam, A., Huebner, D., Dalal, M. & Illidge, T., 1 Jan 2019, In: British Journal of Haematology. 184, 2, p. 202-214 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
Barrington, S. F., Phillips, E. H., Counsell, N., Hancock, B., Pettengell, R., Johnson, P., Townsend, W., Culligan, D., Popova, B., Clifton-Hadley, L., McMillan, A., Hoskin, P., O'Doherty, M. J., Illidge, T. & Radford, J., 2019, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 20, p. 1732-1741Research output: Contribution to journal › Article › peer-review
Open AccessFile91 Downloads (Pure) -
The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper
British Society for Haematology Guidelines, 2019, In: British Journal of Haematology.Research output: Contribution to journal › Article › peer-review
Open Access -
2018
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
Gilson, D., Whittaker, S. J., Child, F. J., Scarisbrick, J. J., Illidge, T. M., Parry, E. J., Mohd Mustapa, M. F., Exton, L. S., Kanfer, E., Rezvani, K., Dearden, C. E. & Morris, S. L., 17 Dec 2018, In: The British journal of dermatology.Research output: Contribution to journal › Article › peer-review
-
Clinical Development of Novel Drug-Radiotherapy Combinations
Ahmad, S. S., Crittenden, M. R., Tran, P. T., Kluetz, P. G., Blumenthal, G. M., Bulbeck, H., Baird, R. D., Williams, K. J., Illidge, T., Hahn, S. M., Lawrence, T. S., Spears, P. A., Walker, A. J. & Sharma, R. A., 29 Nov 2018, (E-pub ahead of print) In: Clinical cancer research : an official journal of the American Association for Cancer Research.Research output: Contribution to journal › Article › peer-review
-
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas
Fanale, M. A., Horwitz, S. M., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Illidge, T., Uttarwar, M., Lee, S.-Y., Ren, H., Kennedy, D. A. & Shustov, A. R., 10 May 2018, In: Blood. 131, 19, p. 2120-2124Research output: Contribution to journal › Article › peer-review
-
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO Guidelines Committee, 1 Oct 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, Supplement_4, p. iv19-iv29Research output: Contribution to journal › Article › peer-review
Open Access -
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany
Zagadailov, E. A., Corman, S., Chirikov, V., Johnson, C., Macahilig, C., Seal, B., Dalal, M. R., Broeckelmann, P. J. & Illidge, T., 2018, In: Leukemia and Lymphoma. 59, 6, p. 1413-1419Research output: Contribution to journal › Article › peer-review
Open Access1 Downloads (Pure) -
Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity
Walshaw, R. C. & Illidge, T. M., 2018, In: Leukemia & lymphoma. p. 1-2Research output: Contribution to journal › Article › peer-review
-
2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment
Searle, E., Telfer, B., Mukherjee, D., Forster, D., Davies, B. R., Williams, K., Stratford, I. & Illidge, T., 30 Oct 2017, In: EMBO Molecular Medicine . 9, 12, p. 1646-1659Research output: Contribution to journal › Article › peer-review
Open Access -
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (vol 31, pg 1611, 2017)
Cheadle, E. J., Lipowska-Bhalla, G., Dovedi, S. J., Fagnano, E., Klein, C., Honeychurch, J. & Illidge, T. M., 2017, In: Leukemia. 31, 10, p. 2278-2278Research output: Contribution to journal › Article › peer-review
Open Access -
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
Bröckelmann, P. J., Zagadailov, E. A., Corman, S. L., Chirikov, V., Johnson, C., Macahilig, C., Seal, B., Dalal, M. R. & Illidge, T., 2017, In: European journal of haematology.Research output: Contribution to journal › Article › peer-review
Open AccessFile69 Downloads (Pure) -
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J., Kennedy, D. A. & Shustov, A., 21 Dec 2017, In: Blood. 130, 25, p. 2709–2717 18 p.Research output: Contribution to journal › Article › peer-review
-
Fractionated radiation therapy stimulates anti-tumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD1 blockade
Dovedi, S., Cheadle, E., Popple, A. L., Poon, E., Morrow, M., Stewart, R., Yusko, E. C., Sanders, C. M., Vignali, M., Emerson, R. O., Robins, H. S., Wilkinson, R. W., Honeychurch, J. & Illidge, T., 22 May 2017, In: Clinical Cancer Research. 23, 18, p. 5514–5526Research output: Contribution to journal › Article › peer-review
Open AccessFile621 Downloads (Pure) -
Immune Checkpoint Inhibitors in Lung Cancer - An Unheralded Opportunity?
Marshall, R., Popple, A., Kordbacheh, T., Honeychurch, J., Faivre-Finn, C. & Illidge, T., 2017, In: Clinical oncology (Royal College of Radiologists (Great Britain)).Research output: Contribution to journal › Article › peer-review
-
2016
Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CD8+ T cells
Dovedi, S., Lipowska-Bhalla, G., Beers, S., Cheadle, E., Mu, L., Glennie, M. J., Illidge, T. & Honeychurch, J., 1 Jul 2016, In: Cancer Immunology Research . 4, 7Research output: Contribution to journal › Article › peer-review
Open AccessFile184 Downloads (Pure) -
Clinical Development of new Drug-Radiotherapy Combinations
Stratford, I., Sharma, R., Plummer, R., K Stock, J., A Greenhalgh, T., Atamar, O., Kelly, S., Clay, R., Adams, R., D Baird, R., Billingham, L., R Brown, S., Buckland, S., Bulbeck, H., J Chalmers, A., Clack, G., N Cranston, A., Damstrup, L., Ferraldeschi, R. & D Forster, M. & 20 others, , 1 Jun 2016, In: Nature Reviews Clinical Oncology. 13, p. 627-642 16 p.Research output: Contribution to journal › Article › peer-review
Open Access